176 related articles for article (PubMed ID: 10771458)
1. The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.
Miceli JJ; Smith M; Robarge L; Morse T; Laurent A
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):71S-76S. PubMed ID: 10771458
[TBL] [Abstract][Full Text] [Related]
2. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.
Miceli JJ; Anziano RJ; Robarge L; Hansen RA; Laurent A
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):65S-70S. PubMed ID: 10771457
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
[TBL] [Abstract][Full Text] [Related]
4. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Potkin SG; Preskorn S; Hochfeld M; Meng X
J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
[TBL] [Abstract][Full Text] [Related]
5. Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers.
Wilner KD; Tensfeldt TG; Baris B; Smolarek TA; Turncliff RZ; Colburn WA; Hansen RA
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):15S-20S. PubMed ID: 10771449
[TBL] [Abstract][Full Text] [Related]
6. Ziprasidone and the pharmacokinetics of a combined oral contraceptive.
Muirhead GJ; Harness J; Holt PR; Oliver S; Anziano RJ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):49S-56S. PubMed ID: 10771454
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid.
Wilner KD; Hansen RA; Folger CJ; Geoffroy P
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):57S-60S. PubMed ID: 10771455
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults.
Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
Clin Drug Investig; 2014 Oct; 34(10):691-9. PubMed ID: 25047407
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.
Miceli JJ; Wilner KD; Hansen RA; Johnson AC; Apseloff G; Gerber N
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):5S-13S. PubMed ID: 10771448
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers.
Swart PJ; Krauwinkel WJ; Smulders RA; Smith NN
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):33-6. PubMed ID: 16867168
[TBL] [Abstract][Full Text] [Related]
12. Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.
Boinpally R; Gad N; Gupta S; Periclou A
Clin Ther; 2014 Nov; 36(11):1638-49. PubMed ID: 25236915
[TBL] [Abstract][Full Text] [Related]
13. Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.
Abbas R; Leister C; El Gaaloul M; Chalon S; Sonnichsen D
Clin Ther; 2012 Sep; 34(9):2011-9.e1. PubMed ID: 22884766
[TBL] [Abstract][Full Text] [Related]
14. Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug-drug interaction study in healthy male Korean volunteers.
Noh YH; Lim HS; Jin SJ; Kim MJ; Kim YH; Sung HR; Choi HY; Bae KS
Clin Ther; 2012 May; 34(5):1182-94. PubMed ID: 22534255
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers.
Mahatthanatrakul W; Sriwiriyajan S; Ridtitid W; Boonleang J; Wongnawa M; Rujimamahasan N; Pipatrattanaseree W
J Clin Pharm Ther; 2012 Apr; 37(2):221-5. PubMed ID: 21518375
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.
Everson G; Lasseter KC; Anderson KE; Bauer LA; Carithens RL; Wilner KD; Johnson A; Anziano RJ; Smolarek TA; Turncliff RZ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):21S-26S. PubMed ID: 10771450
[TBL] [Abstract][Full Text] [Related]
17. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers.
Ridtitid W; Wongnawa M; Mahatthanatrakul W; Raungsri N; Sunbhanich M
J Clin Pharm Ther; 2005 Jun; 30(3):285-90. PubMed ID: 15896247
[TBL] [Abstract][Full Text] [Related]
18. Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity.
Brynne N; Forslund C; Hallén B; Gustafsson LL; Bertilsson L
Br J Clin Pharmacol; 1999 Oct; 48(4):564-72. PubMed ID: 10583027
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
Miceli JJ; Wilner KD; Swan SK; Tensfeldt TG
J Clin Pharmacol; 2005 Jun; 45(6):620-30. PubMed ID: 15901743
[TBL] [Abstract][Full Text] [Related]
20. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
